Search Results

There are 14725 results for: content related to: Erratum: Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data

  1. Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data

    Pharmaceutical Statistics

    Volume 9, Issue 4, October/December 2010, Pages: 313–330, Shuying Yang and James Roger

    Article first published online : 30 DEC 2009, DOI: 10.1002/pst.400

  2. Issue Information

    Pharmaceutical Statistics

    Volume 14, Issue 3, May/June 2015, Pages: i–iii,

    Article first published online : 12 MAY 2015, DOI: 10.1002/pst.1643

  3. A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studies

    Pharmaceutical Statistics

    Volume 11, Issue 1, January/February 2012, Pages: 14–23, Carmen Navarro-Fontestad, Isabel González-Álvarez, Carlos Fernández-Teruel, Marival Bermejo and Vicente Germán Casabó

    Article first published online : 25 JAN 2011, DOI: 10.1002/pst.484

  4. Issue Information

    Pharmaceutical Statistics

    Volume 14, Issue 2, March/April 2015, Pages: i–iii,

    Article first published online : 19 MAR 2015, DOI: 10.1002/pst.1642

  5. A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies

    Pharmaceutical Statistics

    Volume 11, Issue 4, July/August 2012, Pages: 325–333, Lee Kien Foo, James McGree and Stephen Duffull

    Article first published online : 12 MAR 2012, DOI: 10.1002/pst.1509

  6. Some recent books about six sigma

    Pharmaceutical Statistics

    Volume 1, Issue 1, June 2002, Pages: 67–68, Dennis Lendrem and Iain GRANT

    Article first published online : 12 JUN 2002, DOI: 10.1002/pst.10

  7. Disappointing dichotomies

    Pharmaceutical Statistics

    Volume 2, Issue 4, October/December 2003, Pages: 239–240, Stephen Senn

    Article first published online : 5 DEC 2003, DOI: 10.1002/pst.90

  8. Book Reviews

    Pharmaceutical Statistics

    Volume 2, Issue 3, July/September 2003, Page: 229, Peter Lane

    Article first published online : 2 SEP 2003, DOI: 10.1002/pst.72

  9. Editorial

    Pharmaceutical Statistics

    Volume 2, Issue 4, October/December 2003, Pages: 237–238, Byron Jones, Christy Chuang-Stein and Larry Furlong

    Article first published online : 5 DEC 2003, DOI: 10.1002/pst.94

  10. Biostatistics in Clinical Trials (2001). Redmond, C. and Colton, T. (eds) ISBN 0-471-82211-6; pp 522; £165.00, €272.30, $245.00 John Wiley & Sons; http://www.wileyeurope.com/cda/product/0,,0471822116,00.html

    Pharmaceutical Statistics

    Volume 1, Issue 2, December 2002, Page: 148, De Phung

    Article first published online : 9 JAN 2003, DOI: 10.1002/pst.25

  11. A note on effective sample size for constructing confidence intervals for the difference of two proportions

    Pharmaceutical Statistics

    Volume 11, Issue 2, March/April 2012, Pages: 163–169, Guanghan F. Liu

    Article first published online : 15 FEB 2012, DOI: 10.1002/pst.540

  12. Designing a non-inferiority study in kidney transplantation: a case study

    Pharmaceutical Statistics

    Volume 10, Issue 5, September/October 2011, Pages: 427–432, Steffen Witte, Heinz Schmidli, Anthony O'Hagan and Amy Racine

    Article first published online : 16 SEP 2011, DOI: 10.1002/pst.511

  13. Book Reviews

    Pharmaceutical Statistics

    Volume 2, Issue 2, April/June 2003, Page: 151, Peter Lane

    Article first published online : 10 JUN 2003, DOI: 10.1002/pst.58

  14. A Bayesian approach to the statistical analysis of device preference studies

    Pharmaceutical Statistics

    Volume 11, Issue 2, March/April 2012, Pages: 149–156, Haoda Fu, Yongming Qu, Baojin Zhu and William Huster

    Article first published online : 28 FEB 2012, DOI: 10.1002/pst.522

  15. Statistical support to non-clinical

    Pharmaceutical Statistics

    Volume 1, Issue 2, December 2002, Pages: 71–73, Dennis Lendrem

    Article first published online : 9 JAN 2003, DOI: 10.1002/pst.29

  16. An evaluation of methods for testing hypotheses relating to two endpoints in a single clinical trial

    Pharmaceutical Statistics

    Volume 11, Issue 2, March/April 2012, Pages: 107–117, Ting-Li Su, Ekkehard Glimm, John Whitehead and Mike Branson

    Article first published online : 15 FEB 2012, DOI: 10.1002/pst.504

  17. Assessing non-inferiority to an aggregate response with an application to development of pneumococcal conjugate vaccines

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 332–340, Yi Pan, Guanghan F. Liu and Michael J. Dallas

    Article first published online : 9 NOV 2010, DOI: 10.1002/pst.470

  18. Sample sizes for trials involving multiple correlated must-win comparisons

    Pharmaceutical Statistics

    Volume 11, Issue 2, March/April 2012, Pages: 177–185, Steven A. Julious and Nikki E. McIntyre

    Article first published online : 1 MAR 2012, DOI: 10.1002/pst.515

  19. Statistical Development of Quality in Medicine Winkel Per, Zhang Nien Fan (2007) ISBN 0470027776; 263 pages; $90.00, £50.50 Wiley; http://www.wiley.com

    Pharmaceutical Statistics

    Volume 11, Issue 1, January/February 2012, Page: 89, Mariano Ruiz Espejo

    Article first published online : 11 MAR 2011, DOI: 10.1002/pst.481

  20. Effects of unstratified and centre-stratified randomization in multi-centre clinical trials

    Pharmaceutical Statistics

    Volume 10, Issue 1, January/February 2011, Pages: 50–59, Vladimir V. Anisimov

    Article first published online : 28 JAN 2010, DOI: 10.1002/pst.412